- Home
- LIF vs AXSM Comparison
LIF vs AXSM Comparison
Compare LIF & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIF
- AXSM
- Stock Information
- Founded
- LIF 2008
- AXSM 2012
- Country
- LIF United States
- AXSM United States
- Employees
- LIF N/A
- AXSM N/A
- Industry
- LIF
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- LIF
- AXSM Health Care
- Exchange
- LIF Nasdaq
- AXSM Nasdaq
- Market Cap
- LIF 4.8B
- AXSM 5.1B
- IPO Year
- LIF N/A
- AXSM 2015
- Fundamental
- Price
- LIF $65.58
- AXSM $105.00
- Analyst Decision
- LIF Strong Buy
- AXSM Strong Buy
- Analyst Count
- LIF 6
- AXSM 17
- Target Price
- LIF $59.50
- AXSM $171.65
- AVG Volume (30 Days)
- LIF 771.2K
- AXSM 649.3K
- Earning Date
- LIF 08-11-2025
- AXSM 08-04-2025
- Dividend Yield
- LIF N/A
- AXSM N/A
- EPS Growth
- LIF N/A
- AXSM N/A
- EPS
- LIF 0.04
- AXSM N/A
- Revenue
- LIF $396,881,000.00
- AXSM $432,157,000.00
- Revenue This Year
- LIF $27.69
- AXSM $62.84
- Revenue Next Year
- LIF $22.16
- AXSM $60.02
- P/E Ratio
- LIF $512.60
- AXSM N/A
- Revenue Growth
- LIF 26.15
- AXSM 72.16
- 52 Week Low
- LIF $28.94
- AXSM $72.21
- 52 Week High
- LIF $67.11
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- LIF N/A
- AXSM 47.99
- Support Level
- LIF N/A
- AXSM $102.26
- Resistance Level
- LIF N/A
- AXSM $106.35
- Average True Range (ATR)
- LIF 0.00
- AXSM 3.09
- MACD
- LIF 0.00
- AXSM 0.15
- Stochastic Oscillator
- LIF 0.00
- AXSM 66.44
About LIF Life360 Inc. Common Stock
Life360 is the world's largest family-focused social network, with over 50 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.